# Study of IMC-S118AI in Type 1 Diabetes

> **NCT07493122** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Immunocore Ltd** · enrollment: 154 (estimated)

## Conditions studied

- Type 1 Diabetes
- Type 1 Diabetes (T1D)
- Diabetes Type 1

## Interventions

- **BIOLOGICAL:** IMC-S118AI

## Key facts

- **NCT ID:** NCT07493122
- **Lead sponsor:** Immunocore Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2030-11
- **Final completion:** 2030-11
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07493122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07493122, "Study of IMC-S118AI in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07493122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*